跳至主要内容
临床试验/JPRN-UMIN000032183
JPRN-UMIN000032183已完成未知

A FOIR Treatment - A FOIR Treatment

Japan Clinical Trial Association0 个研究点目标入组 12 人开始时间: 2018年4月11日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 59years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects during pregnancy, lactating 2. Subjects who have experienced medical, surgery affecting the test site such as neck, shoulder, hip, leg 3. Subject with severe pain

研究者

相似试验

未知
3 期
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
JPRN-jRCT2080222813ovartis Pharma K.K.20
进行中(未招募)
不适用
T CELL DEPLETED HEMATOPOIETIC STEM CELL TRANSPLANT POST REDUCED INTENSITY CONDITIONING AND EARLY USE OF CYCLOPHOPHAMIDE-CLL patients with refractoriness to fludarabine or other chemotherapy due , Follicular lymphoma with either unfavourable cytogenetics such as complex karyotype, del17p, mutations in TP53, minus 1p- Hodgkin's Lymphoma relapsed after autologous transplantation, not elegible for immunotherapy with anti-CD30,-Multiple myeloma relapsing after autologous transplantation, with unfavourable cytogenetics in either partial or complete remissionMedDRA version: 17.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 17.0Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864MedDRA version: 17.0Level: LLTClassification code 10024341Term: Leukemia lymphoidSystem Organ Class: 100000004864
EUCTR2013-003628-35-ITAzienda Ospedaliero-Universitaria di Parma10
已完成
不适用
Development of a comprehensive treatment based on psychosocial approach for support for the individuals with early psychosisPsychotic disorders A nurse working in a Psychiatric hospital
JPRN-UMIN000031268Tohoku University20
进行中(未招募)
1 期
A study to evaluate the cognitive effect of a product named vortioxetine (used in depression). These effects willbe compared to those induced by a marketed comparator and a placebo. Investigator and subjects will be blinded.
EUCTR2014-000229-19-FIH. Lundbeck A/S195
进行中(未招募)
1 期
Efficacy of KL1333 in adult patients with primary mitochondrial diseaseAdult patients with primary mitochondrial diseaseMedDRA version: 20.0Level: HLTClassification code 10052637Term: Genetic mitochondrial abnormalities NECSystem Organ Class: 100000004850
EUCTR2021-002846-33-DKAbliva AB180